Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review).

ABSTRACT: Thyroid cancer (TC) is a broad classification of neoplasms that includes differentiated thyroid cancer (DTC) as a common histological subtype. DTC is characterized by an increased mortality rate in advanced stages, which contributes to the overall high mortality rate of DTC. This progression is mainly attributed to alterations in molecular driver genes, resulting in changes in phenotypes such as invasion, metastasis and dedifferentiation. Clinical management of DTC is challenging due to insufficient diagnostic and therapeutic options. The advent of-omics technology has presented a promising avenue for the diagnosis and treatment of DTC. Identifying molecular markers that can predict the early progression of DTC to a late adverse outcome is essential for precise diagnosis and treatment. The

SUBMITTER: Yang S 

PROVIDER: S-EPMC10433702 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature